Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic human pulp mesenchymal stem cells + hyaluronic acid polymers
- Development stage
- Unknown
- Lead developer
- Fifth Affiliated Hospital of Guangzhou Medical University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Local
01
Overview
A combination cell therapy product comprising allogeneic stem cells from human exfoliated deciduous teeth (SHED) and a hyaluronic acid polymer scaffold. Developed by the Fifth Affiliated Hospital of Guangzhou Medical University, the treatment is designed for pulp regeneration in permanent teeth affected by pulp necrosis. SHED are highly proliferative mesenchymal stem cells capable of differentiating into various cell types, including odontoblasts. The hyaluronic acid component acts as a supportive matrix to facilitate cell delivery, survival, and tissue integration within the root canal, aiming to restore the biological function and vitality of the tooth.
- Other names
- SHED mixed with hyaluronic acid polymersAllogeneic human pulp mesenchymal stem cells mixed with hyaluronic acid polymersSHED Polymerization
Beyond the preview
Go deeper on allogeneic human pulp mesenchymal stem cells + hyaluronic acid polymers.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic human pulp mesenchymal stem cells + hyaluronic acid polymers.